Log in

Bellicum Pharmaceuticals News Headlines (NASDAQ:BLCM)

$0.82
-0.04 (-4.65 %)
(As of 11/21/2019 01:05 AM ET)
Today's Range
$0.82
Now: $0.82
$0.88
50-Day Range
$0.76
MA: $0.90
$1.29
52-Week Range
$0.72
Now: $0.82
$5.44
Volume306,000 shs
Average Volume593,056 shs
Market Capitalization$40.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Headlines

Bellicum Pharmaceuticals (NASDAQ BLCM) News Headlines

Source:
DateHeadline
Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Sees Large Growth in Short InterestBellicum Pharmaceuticals Inc (NASDAQ:BLCM) Sees Large Growth in Short Interest
www.americanbankingnews.com - November 14 at 12:42 PM
Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Short Interest UpdateBellicum Pharmaceuticals Inc (NASDAQ:BLCM) Short Interest Update
www.americanbankingnews.com - November 11 at 11:47 PM
Bellicum Pharmaceuticals Presents Encouraging Preclinical Data for GoCAR-NK Cell Program at Society for Immunotherapy of Cancer Annual MeetingBellicum Pharmaceuticals Presents Encouraging Preclinical Data for GoCAR-NK Cell Program at Society for Immunotherapy of Cancer Annual Meeting
finance.yahoo.com - November 8 at 7:53 AM
Edited Transcript of BLCM earnings conference call or presentation 6-Nov-19 10:00pm GMTEdited Transcript of BLCM earnings conference call or presentation 6-Nov-19 10:00pm GMT
finance.yahoo.com - November 7 at 7:31 AM
Bellicum Pharmaceuticals, Inc. (BLCM) CEO Rick Fair on Q3 2019 Results - Earnings Call TranscriptBellicum Pharmaceuticals, Inc. (BLCM) CEO Rick Fair on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 1:21 AM
Bellicum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Operational UpdateBellicum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Operational Update
finance.yahoo.com - November 6 at 8:20 PM
Bellicum Pharmaceuticals (BLCM) Reports Q3 Loss, Lags Revenue EstimatesBellicum Pharmaceuticals (BLCM) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 6 at 8:20 PM
Bellicum Pharmaceuticals Announces Presentation on CAR-NK Cell Program at SITC 2019Bellicum Pharmaceuticals Announces Presentation on CAR-NK Cell Program at SITC 2019
finance.yahoo.com - October 31 at 5:58 PM
Bellicum Pharmaceuticals (BLCM) Set to Announce Earnings on WednesdayBellicum Pharmaceuticals (BLCM) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 31 at 9:03 AM
Bellicum Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Corporate UpdateBellicum Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - October 30 at 9:05 AM
Earnings Preview: Bellicum Pharmaceuticals (BLCM) Q3 Earnings Expected to DeclineEarnings Preview: Bellicum Pharmaceuticals (BLCM) Q3 Earnings Expected to Decline
finance.yahoo.com - October 29 at 1:16 PM
Introducing Bellicum Pharmaceuticals (NASDAQ:BLCM), The Stock That Tanked 95%Introducing Bellicum Pharmaceuticals (NASDAQ:BLCM), The Stock That Tanked 95%
finance.yahoo.com - October 26 at 1:16 PM
Top Ranked Momentum Stocks to Buy for September 23rdTop Ranked Momentum Stocks to Buy for September 23rd
finance.yahoo.com - September 23 at 1:49 PM
Bellicum: Moving Toward MAA Submission For Rivo-CelBellicum: Moving Toward MAA Submission For Rivo-Cel
seekingalpha.com - September 9 at 11:54 AM
Bellicum Pharmaceuticals (BLCM) Presents At 2019 Wells Fargo Healthcare Conference - SlideshowBellicum Pharmaceuticals (BLCM) Presents At 2019 Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 6 at 12:47 PM
Do Insiders Own Lots Of Shares In Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)?Do Insiders Own Lots Of Shares In Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)?
finance.yahoo.com - September 3 at 8:08 PM
Bellicum: Strong Trial Data, Poor Share Price, Dire FinancialsBellicum: Strong Trial Data, Poor Share Price, Dire Financials
seekingalpha.com - September 2 at 6:57 PM
Bellicum Pharmaceuticals to Participate in Three Healthcare Investor Conferences during SeptemberBellicum Pharmaceuticals to Participate in Three Healthcare Investor Conferences during September
finance.yahoo.com - August 29 at 7:51 AM
Bellicum Pharma +6.6% on Baker Bros. stakeBellicum Pharma +6.6% on Baker Bros. stake
seekingalpha.com - August 22 at 11:23 PM
Houston pharma co. raises $69.6M through public offering, private placementHouston pharma co. raises $69.6M through public offering, private placement
finance.yahoo.com - August 21 at 11:00 PM
Bellicum Pharmaceuticals Announces Aggregate Gross Proceeds of $69.6 Million from $139.6 Million Public Offering and Private PlacementBellicum Pharmaceuticals Announces Aggregate Gross Proceeds of $69.6 Million from $139.6 Million Public Offering and Private Placement
finance.yahoo.com - August 21 at 11:00 PM
Houston pharma co. raising $139.6M through public offering, private placementHouston pharma co. raising $139.6M through public offering, private placement
finance.yahoo.com - August 20 at 11:43 PM
CORRECTING and REPLACING -Bellicum Pharmaceuticals, Inc.CORRECTING and REPLACING -Bellicum Pharmaceuticals, Inc.
finance.yahoo.com - August 17 at 12:22 AM
Bellicum Pharma launches $53M equity offeringBellicum Pharma launches $53M equity offering
seekingalpha.com - August 16 at 12:07 PM
Bellicum prices equity offering at $1Bellicum prices equity offering at $1
seekingalpha.com - August 16 at 12:07 PM
CORRECTING and REPLACING - Bellicum Pharmaceuticals, Inc.CORRECTING and REPLACING - Bellicum Pharmaceuticals, Inc.
www.marketwatch.com - August 16 at 12:07 PM
Bellicum Pharmaceuticals Announces Pricing of Bellicum Pharmaceuticals Announces Pricing of $139.6 Million Public Offering and Private PlacementBellicum Pharmaceuticals Announces Pricing of Bellicum Pharmaceuticals Announces Pricing of $139.6 Million Public Offering and Private Placement
finance.yahoo.com - August 16 at 12:07 PM
Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private PlacementBellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement
finance.yahoo.com - August 15 at 7:58 PM
Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational UpdateBellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update
www.nasdaq.com - August 5 at 11:46 PM
Bellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseBellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 30 at 11:26 PM
Bellicum: Ready To Transition Into A Commercial Stage CompanyBellicum: Ready To Transition Into A Commercial Stage Company
seekingalpha.com - July 30 at 12:29 AM
Should You Worry About Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Pay?Should You Worry About Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Pay?
finance.yahoo.com - July 19 at 8:58 AM
Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational TrialBellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial
finance.yahoo.com - July 8 at 8:13 AM
Does Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Have A High Beta?Does Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) Have A High Beta?
finance.yahoo.com - June 13 at 12:52 PM
Bellicum Pharmaceuticals Provides Interim Data for BPX-601 in Patients with Metastatic Pancreatic Cancer for Presentation at ASCO Annual MeetingBellicum Pharmaceuticals Provides Interim Data for BPX-601 in Patients with Metastatic Pancreatic Cancer for Presentation at ASCO Annual Meeting
finance.yahoo.com - June 1 at 5:42 PM
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) and Encourages Bellicum Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) and Encourages Bellicum Investors to Contact the Firm
finance.yahoo.com - June 1 at 8:18 AM
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 31 at 6:58 PM
Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare ConferenceBellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 29 at 7:01 PM
(BLCM) Alert: Johnson Fistel, LLP Announces Investigation of Bellicum Pharmaceuticals, Inc.; Long Term Investors Encouraged to Contact Firm(BLCM) Alert: Johnson Fistel, LLP Announces Investigation of Bellicum Pharmaceuticals, Inc.; Long Term Investors Encouraged to Contact Firm
finance.yahoo.com - May 21 at 6:21 AM
Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual MeetingBellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting
finance.yahoo.com - May 15 at 9:49 PM
Bellicum Pharmaceuticals (BLCM) Reports Q1 Loss, Tops Revenue EstimatesBellicum Pharmaceuticals (BLCM) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 7 at 7:05 PM
Bellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseBellicum Pharmaceuticals (BLCM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - May 7 at 7:05 PM
Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Operational UpdateBellicum Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Operational Update
finance.yahoo.com - May 7 at 8:20 AM
Bellicum Pharmaceuticals Inc.Bellicum Pharmaceuticals Inc.
www.barrons.com - March 28 at 8:22 AM
Bellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy SummitBellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy Summit
finance.yahoo.com - March 27 at 8:20 AM
Edited Transcript of BLCM earnings conference call or presentation 12-Mar-19 9:00pm GMTEdited Transcript of BLCM earnings conference call or presentation 12-Mar-19 9:00pm GMT
finance.yahoo.com - March 13 at 8:09 AM
Bellicum Pharmaceuticals, Inc. (BLCM) After Hours TradingBellicum Pharmaceuticals, Inc. (BLCM) After Hours Trading
www.nasdaq.com - March 12 at 10:53 PM
Bellicum Pharmaceuticals, Inc.s (BLCM) CEO Rick Fair on Q4 2018 Results - Earnings Call TranscriptBellicum Pharmaceuticals, Inc.'s (BLCM) CEO Rick Fair on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 10:53 PM
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018
finance.yahoo.com - March 12 at 10:53 PM
Bellicum Pharmaceuticals Q4 Earnings PreviewBellicum Pharmaceuticals Q4 Earnings Preview
www.benzinga.com - March 12 at 8:21 AM
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel